Equities
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in DKKIncome statement in DKKView more

Year on year Coloplast A/S had little change in net income (from 4.71bn to 4.78bn) despite revenues that grew 8.51% from 22.58bn to 24.50bn. A contributing factor has been an increase in the cost of goods sold as a percent of sales from 31.22% to 33.36%.
Gross margin67.52%
Net profit margin18.88%
Operating margin26.83%
Return on assets11.87%
Return on equity43.17%
Return on investment16.19%
More ▼

Cash flow in DKKView more

In 2023, Coloplast A/S increased its cash reserves by 120.05%, or 497.00m. Cash Flow from Financing totalled 5.27bn or 21.49% of revenues. In addition the company generated 4.23bn in cash from operations while cash used for investing totalled 8.96bn.
Cash flow per share27.78
Price/Cash flow per share30.90
Book value per share73.49
Tangible book value per share-62.48
More ▼

Balance sheet in DKKView more

Coloplast A/S has a Debt to Total Capital ratio of 59.75%, a lower figure than the previous year's 262.91%.
Current ratio0.8536
Quick ratio0.5587
Total debt/total equity1.48
Total debt/total capital0.5975
More ▼

Growth rates in DKK

SmartText is unavailable
Div yield(5 year avg)2.23%
Div growth rate (5 year)5.59%
Payout ratio (TTM)93.76%
EPS growth(5 years)4.16
EPS (TTM) vs
TTM 1 year ago
-1.75
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.